Formulations comprising valsartan for treating diabetes or microalbuminuria

摘要

The present invention is directed to a composition consisting of the active ingredient valsartan and at least one pharmaceutically acceptable excipient for the manufacture of a medicament for the prevention, delay of progression or treatment of diabetes, in particular type 2 diabetes. The present invention is also directed to a composition consisting of the active ingredient valsartan and at least one pharmaceutically acceptable excipient for the manufacture of a medicament for the improvement of microalbuminurea.